Smoking cessation electronic visit (e-visit) for Smoking, Cessation
Phase-Based Progress Estimates
Effectiveness
Safety
Smoking, Cessation
Smoking cessation e-visit - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is testing whether an electronic visit (e-visit) for smoking cessation is effective. Participants will be assigned at random to either receive the e-visit or not. The e-visit will be in the form of an online questionnaire about smoking history, motivation to quit, and preferences for quitting medications. If participants are randomized to the e-visit group, they may receive a prescription for a smoking cessation medication, but they are not required to take it. The study will last 24 weeks and consist of four time points where participants will answer questionnaires and provide breath samples.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
6 Primary · 0 Secondary · Reporting Duration: Month 6
Month 6
Cigarettes smoking
E-visit Acceptability
E-visit Adoption
Number of participants who utilized smoking cessation treatment
Quit attempts
Seven-day point prevalence abstinence
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Treatment as usual (TAU)
1 of 2
Smoking cessation electronic visit (e-visit)
1 of 2
Active Control
Experimental Treatment
672 Total Participants · 2 Treatment Groups
Primary Treatment: Smoking cessation electronic visit (e-visit) · No Placebo Group · N/A
Smoking cessation electronic visit (e-visit)
Behavioral
Experimental Group · 1 Intervention: Smoking cessation e-visit · Intervention Types: BehavioralTreatment as usual (TAU)
Behavioral
ActiveComparator Group · 1 Intervention: Treatment As Usual · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit
2019
N/A
~60
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 6
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
12,989 Previous Clinical Trials
41,298,386 Total Patients Enrolled
83 Trials studying Smoking, Cessation
1,092,118 Patients Enrolled for Smoking, Cessation
Medical University of South CarolinaLead Sponsor
833 Previous Clinical Trials
5,372,552 Total Patients Enrolled
15 Trials studying Smoking, Cessation
7,447 Patients Enrolled for Smoking, Cessation
Eligibility Criteria
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You are the owner of an iOS or Android smartphone to provide remote CO.
You have a valid mailing address.
You are fluent in English.\n
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments